Liver disease in cystic fibrosis.
Tanner
M S
MS
Department of Paediatrics, University of Sheffield.
Taylor
C J
CJ
D000293:Adolescent; D000328:Adult; D001649:Bile Duct Diseases / Q000150:complications; D003550:Cystic Fibrosis / Q000150:complications*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D004198:Disease Susceptibility; D015316:Genetic Therapy; D006801:Humans; D008107:Liver Diseases / Q000209:etiology* / Q000378:metabolism / Q000628:therapy; D008565:Membrane Proteins / Q000032:analysis; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
C505032:CFTR protein, human; D008565:Membrane Proteins; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D014580:Ursodeoxycholic Acid